Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Boyko · SciRah

Researcher profile · Semantic Scholar

A. Boyko

Share profile

A. Boyko — researcher profile on SciRah

h-index: 25
Works: 161
Citations: 2,498

Most-cited papers

International consensus on quality standards for brain health-focused care in multiple sclerosis
J. Hobart, A. Bowen, G. Pepper, H. Crofts +23 more
2018Multiple Sclerosis88 citations Open access
Semantic Scholar
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
M. Boziki, Evangelia Kesidou, Paschalis Theotokis, A. Mentis +6 more
2020Brain Science76 citations Open access
Semantic Scholar
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.
N. Baulina, O. Kulakova, I. Kiselev, G. Osmak +3 more
2018Journal of Neuroimmunology57 citations
Semantic Scholar
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies
A. Boyko, M. Melnikov
2020Brain Science48 citations Open access
Semantic Scholar
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
C. Tur, Anne-Laure Dubessy, S. Otero-Romero, M. Amato +45 more
2022Multiple Sclerosis44 citations Open access
Semantic Scholar
The influence of glatiramer acetate on Th17-immune response in multiple sclerosis
M. Melnikov, S. Sharanova, A. Sviridova, V. Rogovskii +7 more
2020PLoS ONE30 citations Open access
Semantic Scholar
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
I. Kiselev, V. Bashinskaya, N. Baulina, M. Kozin +4 more
2019Multiple Sclerosis and Related Disorders29 citations
Semantic Scholar
MiRNAs from DLK1-DIO3 Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases Signaling
N. Baulina, G. Osmak, I. Kiselev, E. Popova +3 more
2019Cells29 citations Open access
Semantic Scholar
Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides
A. Mamedov, Nadezhda L. Vorobyeva, I. Filimonova, M. Zakharova +16 more
2020Frontiers in Immunology27 citations Open access
Semantic Scholar
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis
G. Comi, Yuval Dadon, N. Sasson, J. Steinerman +12 more
2021Multiple Sclerosis26 citations
Semantic Scholar
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
E. Dubchenko, A. Ivanov, N. Spirina, N. Smirnova +4 more
2020Brain Science25 citations Open access
Semantic Scholar
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
M. Melnikov, M. Pashenkov, A. Boyko
2021International Journal of Molecular Sciences21 citations Open access
Semantic Scholar
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS.
G. Cutter, A. Veneziano, A. Grinspan, Mahir Al-Banna +8 more
2019Multiple Sclerosis and Related Disorders20 citations Open access
Semantic Scholar
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years.
Ann D. Bass, R. Arroyo, A. Boster, A. Boyko +14 more
2020Multiple Sclerosis and Related Disorders18 citations Open access
Semantic Scholar
The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis.
M. Melnikov, V. Rogovskii, A. Boyko, M. Pashenkov
2018Multiple Sclerosis and Related Disorders16 citations
Semantic Scholar
The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care
E. Gusev, M. Martynov, A. Boyko, I. Voznyuk +4 more
2021Neuroscience and Behavioral Physiology15 citations Open access
Semantic Scholar
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis.
A. Sviridova, V. Rogovskii, V. Kudrin, M. Pashenkov +2 more
2021Journal of Neuroimmunology15 citations
Semantic Scholar
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].
O. Boyko, A. Boyko, P. Yakovlev, A. Zinkina-Orikhan +6 more
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova15 citations
Semantic Scholar
Determination of S-adenosylmethionine and S-adenosylhomocysteine in blood plasma by UPLC with fluorescence detection.
A. Ivanov, E. Dubchenko, M. P. Kruglova, E. Virus +6 more
2019Journal of chromatography. B, Analytical technologies in the biomedical and life sciences14 citations
Semantic Scholar
Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as high MS risk group
A. Boyko
2020Multiple Sclerosis12 citations
Semantic Scholar
[Anxiety and depressive psychopathological characteristics of patients with multiple sclerosis at different stages of disease].
V. Malygin, A. Boyko, O. E. Konovalova, E. E. Pahtusova +3 more
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova12 citations
Semantic Scholar
Mitonuclear interactions influence multiple sclerosis risk.
M. Kozin, O. Kulakova, I. Kiselev, N. Baulina +2 more
2020Gene10 citations
Semantic Scholar
[Clinical-epidemiological characteristics of multiple sclerosis and neuroopticomyelitis in the Central Asia].
T. Khaibullin, E. Kirillova, R. Bikbaev, A. Boyko
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova10 citations
Semantic Scholar
[The improvement of quality of life of patients with multiple sclerosis over 15-year period].
O. Boyko, M. Tatarinova, E. Popova, M. R. Guseva +2 more
2018Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova10 citations
Semantic Scholar
[The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro].
L. V. Krivenko, A. Sviridova, M. Melnikov, V. Rogovskii +2 more
2020Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova9 citations
Semantic Scholar
Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD.
G. Cutter, A. Veneziano, A. Grinspan, Mahir Al-Banna +8 more
2020Multiple Sclerosis and Related Disorders9 citations
Semantic Scholar
[Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis].
V. Malygin, A. Boyko, O. E. Konovalova, A. Iskandirova +3 more
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova8 citations
Semantic Scholar
[Homocysteine and markers of endothelial dysfunction in multiple sclerosis].
N. Spirina, N. Spirin, E. Kiseleva, E. Dubchenko +1 more
2021Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova6 citations
Semantic Scholar
[Epidemiology of neuromyelitis optica spectrum disorder].
M. A. Sherman, A. Boyko
2021Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova6 citations
Semantic Scholar
[New directions of immunocorrection in multiple sclerosis].
A. Boyko, N. Khachanova, M. Melnikov, S. Sivertseva +4 more
2020Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova6 citations
Semantic Scholar
Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study)
Hans-Peter Hartung, G. Comi, D. L. Arnold, A. Boyko +13 more
20196 citations Open access
Semantic Scholar
[Issues of the current terminology in multiple sclerosis].
A. Boyko, M. R. Guseva, N. Khachanova, E. Gusev
2018Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova6 citations
Semantic Scholar
[Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis].
A. Kabaeva, A. Boyko, O. Kulakova, O. O. Favorova
2020Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova5 citations
Semantic Scholar
The first experience with Angiovit in the combination treatment of acute COVID-19 infection
A. Boyko, N. Shamalov, O. Boyko, E. Arinina +4 more
20205 citations Open access
Semantic Scholar
[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy].
A. Boyko
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova5 citations
Semantic Scholar
Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
A. Boyko, K. Bakhtiyarova, L. V. Brylev, M. Zakharova +13 more
2021Neurology, neuropsychiatry, Psychosomatics4 citations Open access
Semantic Scholar
Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis
A. Boyko, S. Sivertseva, N. Spirin
20204 citations Open access
Semantic Scholar
Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
N. Khachanova, A. Boyko, K. Bakhtiyarova, Y. V. Vlasov +4 more
20194 citations Open access
Semantic Scholar
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
E. Evdoshenko, N. Neofidov, K. Bakhtiyarova, M. Davydovskaya +14 more
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova4 citations
Semantic Scholar
Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
A. Boyko, M. Davydovskaya, N. Khachanova, M. Zakharova +8 more
2019Neurology, neuropsychiatry, Psychosomatics4 citations Open access
Semantic Scholar
COVID-19 vaccination guidelines for patients with multiple sclerosis
N. Khachanova, N. A. Totolyan, Y. V. Vlasov, S. Sivertseva +6 more
2021Neurology, neuropsychiatry, Psychosomatics3 citations Open access
Semantic Scholar
[Ofatumumab - a new drug for the treatment of multiple sclerosis].
A. Boyko, N. Smirnova, I. Shchukin, M. Guseva +1 more
2021Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
[Vaccination and multiple sclerosis at the present stage].
A. Boyko, S. Sivertseva, D. Chemakina, N. Spirin +2 more
2021Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
N. Khachanova, K. Bakhtiyarova, A. Boyko, Y. V. Vlasov +8 more
2020Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
Mitochondrial genome and risk of multiple sclerosis
A. Boyko, M. Kozin, G. Osmak, O. Kulakova +1 more
2019Neurology, neuropsychiatry, Psychosomatics3 citations Open access
Semantic Scholar
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].
A. Boyko, L. P. Bosenko, V. V. Vasilovskiy, L. Volkova +19 more
2019Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
[Dimethylfumarate in the treatment of relapsing-remitting multiple sclerosis].
E. Popova, A. Boyko, E. Orlova
2018Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
[Clinical cases of multiple sclerosis in children with cerebral palsy].
S. Sivertseva, O. Bykova, K. Bakhtiyarova, A. Prilenskaya +6 more
2018Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
[A rare clinical case of comorbidity of early-onset Parkinson's disease and remitting multiple sclerosis].
E. Katunina, O. Boyko, N. N. Shipilova, A. Kabaeva +1 more
2021Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova2 citations
Semantic Scholar
The central vein sign in the differential diagnosis of multiple sclerosis
S. Belov, A. Boyko
2020Neurology, neuropsychiatry, Psychosomatics2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Sivertseva×10
Invite
S. Sivertseva — researcher profile on SciRah
E. Popova×8
Invite
E. Popova — researcher profile on SciRah
N. Khachanova×8
Invite
N. Khachanova — researcher profile on SciRah
M. Melnikov×7
Invite
M. Melnikov — researcher profile on SciRah

×7

Invite

O. Kulakova — researcher profile on SciRah

M. Zakharova×7

Invite

M. Zakharova — researcher profile on SciRah

Invite

N. Spirin — researcher profile on SciRah

Invite

O. Favorova — researcher profile on SciRah

E. Evdoshenko×6

Invite

E. Evdoshenko — researcher profile on SciRah

Invite

I. Kiselev — researcher profile on SciRah

M. Pashenkov×5

Invite

M. Pashenkov — researcher profile on SciRah

Invite

O. Boyko — researcher profile on SciRah